Alyeska Investment Group, L.P. Windtree Therapeutics Inc Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Windtree Therapeutics Inc stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 502,000 shares of WINT stock, worth $2.18 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
502,000Holding current value
$2.18 Million% of portfolio
0.07%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding WINT
# of Institutions
2Shares Held
4.09KCall Options Held
0Put Options Held
0About WINDTREE THERAPEUTICS INC
- Ticker WINT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,627,900
- Market Cap $133M
- Description
- Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...